The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by by β-blockers
- 31 January 1991
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 121 (1), 311-316
- https://doi.org/10.1016/0002-8703(91)90864-e
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Doxazosin in patients with hypertensionEuropean Journal of Clinical Pharmacology, 1988
- Multicentre 12‐week double‐blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1986
- A long‐term double‐blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1986
- Clinical pharmacological studies with doxazosin.British Journal of Clinical Pharmacology, 1986
- On the combination of α- and β-adrenoceptor blockade in hypertensionClinical Pharmacology & Therapeutics, 1983
- Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart FailureDrugs, 1983
- Antihypertensive agents which inhibit sympathetic activity: Potentially adverse effects of combination treatmentAmerican Heart Journal, 1982
- α-Adrenoceptor Blockade by Phentolamine Causes β-Adrenergic Vasodilation by Increased Catecholamine Release Due to Presynaptic α-BlockadeJournal of Cardiovascular Pharmacology, 1982
- Haemodynamic Changes in Hypertension and Their Modification by β-Blockers and PrazosinJournal of Cardiovascular Pharmacology, 1980
- Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.British Journal of Clinical Pharmacology, 1979